{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:52:15Z","timestamp":1761630735216},"reference-count":24,"publisher":"Ommega Online Publishers","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JEHS"],"DOI":"10.15436\/2378-6841.15.007","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T12:21:25Z","timestamp":1438172485000},"page":"1-5","source":"Crossref","is-referenced-by-count":10,"title":["Clarifying the Purported Association between Isotretinoin and Inflammatory Bowel Disease"],"prefix":"10.15436","volume":"1","author":[{"name":"Adjunct Professor, Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA. 1437 Central Avenue, no. 910, Memphis, TN 38104","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven S.","family":"Coughlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6127","published-online":{"date-parts":[[2015,3,27]]},"reference":[{"issue":"3","key":"ref0","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaad.2011.04.016","article-title":"Acne treatment and inflammatory bowel disease: what is the evidence?","volume":"65","author":"Alikhan","year":"2011","unstructured":"1. Alikhan, A., Henderson, G.P., Becker, L., et al. Acne treatment and inflammatory bowel disease: what is the evidence? (2011) J Am AcadDermatol 65(3): 650- 654.","journal-title":"J Am Acad Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0190-9622","issn-type":"print"},{"issue":"4","key":"ref1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/jid.2012.387","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.","volume":"133","author":"Alhusayen","year":"2013","unstructured":"2. Alhusayen, R.O., Juurlink, D.N., Mamdani, M.M., et al. Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. (2013) J Invest Dermatol 133(4): 907- 912.","journal-title":"J Invest Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0022-202X","issn-type":"print"},{"issue":"11","key":"ref2","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1038\/ajg.2009.417","article-title":"Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.","volume":"104","author":"Bernstein","year":"2009","unstructured":"3. Bernstein, C.N., Nugent, Z., Longobardi, T., et al. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. (2009) Am J Gastroenterol 104(11): 2774- 2778.","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/978160805181611001010056","volume-title":"Causal Inference and Scientific Paradigms in Epidemiology","author":"Coughlin","year":"2010","unstructured":"4. Coughlin, S.S. Causal Inference and Scientific Paradigms in Epidemiology. (2010) Bentham Science Publishers, Ltd. 56- 64."},{"issue":"10","key":"ref4","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1038\/ajg.2009.334","article-title":"A causal association between isotretinoin and inflammatory bowel disease has yet to be established.","volume":"104","author":"Crockett","year":"2009","unstructured":"5. Crockett, S.D., Gulati, A., Sandler, R.S., et al. A causal association between isotretinoin and inflammatory bowel disease has yet to be established. (2009) Am J Gastroenterol 104(10): 2387- 2393.","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"issue":"9","key":"ref5","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/ajg.2010.124","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.","volume":"105","author":"Crockett","year":"2010","unstructured":"6. Crockett, S.D., Porter, C.Q., Martin, C.F., et al. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. (2010) Am J Gastroenterol 105(9): 1986- 1993.","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"doi-asserted-by":"crossref","unstructured":"7. Etminan, M., Bird, S.T., Delaney, J.A., et al. Isotretinoin and risk for inflammatory bowel disease. A nested case-control study and meta-analysis of published and unpublished data. (2013) JAMA Dermatol 149(2): 216- 220.","key":"ref6","DOI":"10.1001\/jamadermatol.2013.1344"},{"issue":"4","key":"ref7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/jid.2012.428","article-title":"Toward improved understanding of a potential association between isotretinoin and inflammatory bowel disease.","volume":"133","author":"Femia","year":"2013","unstructured":"8. Femia, A.N., Vleugels, R.A. Toward improved understanding of a potential association between isotretinoin and inflammatory bowel disease. (2013) J Invest Dermatology 133(4): 866- 868.","journal-title":"J Invest Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0022-202X","issn-type":"print"},{"issue":"3","key":"ref8","first-page":"173","volume":"7","author":"Guruvayoonrappan","year":"2008","unstructured":"9. Guruvayoonrappan, C., Kuttan, G. 13 cis-retinoic acid regulates cytokine production and inhibitsangiogenesis by disrupting endothelial cell migration and tube formation. (2008) J ExpTher Oncol 7(3): 173- 182.","journal-title":"J Exp Ther Oncol","ISSN":"http:\/\/id.crossref.org\/issn\/1359-4117","issn-type":"print"},{"issue":"6","key":"ref9","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.4049\/jimmunol.179.6.3724","volume":"179","author":"Kang","year":"2007","unstructured":"10. Kang, S.G., Lim, H.W., Andrisani, O.M., et al. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. (2007) J Immunol 179(6): 3724- 3733.","journal-title":"J Immunol","ISSN":"http:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"issue":"20","key":"ref10","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1001\/jama.2014.2323","article-title":"Treating acne with high-dose isotretinoin.","volume":"311","author":"Owen","year":"2014","unstructured":"11. Owen, C.E. Treating acne with high-dose isotretinoin. (2014) JAMA 311(20): 2121- 2122.","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1124\/mol.106.029579","article-title":"Cellular retinoic acid bioavailability determines epithelial integrity: role of retinoic acid receptor alpha agonists in colitis.","volume":"71","author":"Osanai","year":"2007","unstructured":"12. Osanai, M., Nishikiori, N., Murata, M., et al. Cellular retinoic acid bioavailability determines epithelial integrity: role of retinoic acid receptor alpha agonists in colitis. (2007) MolPharmacol 71(1): 250- 258.","journal-title":"Mol Pharmacol","ISSN":"http:\/\/id.crossref.org\/issn\/0026-895X","issn-type":"print"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.smim.2008.08.002","article-title":"Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells.","volume":"21","author":"Mora","year":"2009","unstructured":"13. Mora, J.R., von Andrian, U.H. Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells. (2009) SeminImmunol 21(1): 28- 35.","journal-title":"Semin Immunol","ISSN":"http:\/\/id.crossref.org\/issn\/1044-5323","issn-type":"print"},{"issue":"5835","key":"ref13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1145697","volume":"317","author":"Mucida","year":"2007","unstructured":"14. Mucida, D., Park, Y., Kim, G., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. (2007) Science 317(5835): 256- 260.","journal-title":"Science","ISSN":"http:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"issue":"1","key":"ref14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/1523-1747.ep12580370","article-title":"Isotretinoin produces significant inhibition of monocyte and neurtrophilchemotaxis in vivo in patients with cystic acne.","volume":"89","author":"Norris","year":"1987","unstructured":"15. Norris, D.A., Osborn, R., Robinson, W., et al. Isotretinoin produces significant inhibition of monocyte and neurtrophilchemotaxis in vivo in patients with cystic acne. (1987) J Invest Dermatol 89(1): 38- 43.","journal-title":"J Invest Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0022-202X","issn-type":"print"},{"issue":"2","key":"ref15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1001\/jamadermatol.2013.1348","article-title":"The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel disease.","volume":"149","author":"Popescu","year":"2013","unstructured":"16. Popescu, C.M., Bigby, M. The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel disease. (2013) JAMA Dermatol 149(2): 221- 222.","journal-title":"JAMA Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/2168-6068","issn-type":"print"},{"issue":"6","key":"ref16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/archdermatol.2011.116","article-title":"Isoretinoin therapy and inflammatory bowel disease.","volume":"147","author":"Popescu","year":"2011","unstructured":"17. Popescu, C.M., Popescu, R. Isoretinoin therapy and inflammatory bowel disease. (2011) Arch Dermatol 147(6): 724- 729.","journal-title":"Arch Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0003-987X","issn-type":"print"},{"issue":"5","key":"ref17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jpag.2013.05.007","volume":"26","author":"Prevost","year":"2013","unstructured":"18. Prevost, N., English,J.C. Isotretinoin: update on controversial issues. (2013) J PediatrAdolescGynecol 26(5): 290- 293.","journal-title":"J Pediatr Adolesc Gynecol","ISSN":"http:\/\/id.crossref.org\/issn\/1083-3188","issn-type":"print"},{"issue":"5","key":"ref18","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1016\/S0016-5085(12)60336-9","article-title":"Isotretinoin and risk of inflammatory bowel disease: a case control study from the French National Health Insurance System.","volume":"142","author":"Racine","year":"2012","unstructured":"19. Racine, A., Cuerq, A., Bijon, A., et al. Isotretinoin and risk of inflammatory bowel disease: a case control study from the French National Health Insurance System. (2012) Gastroenterology 142(5,Suppl 1): S88.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"issue":"4","key":"ref19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/ajg.2014.8","article-title":"Isotretinoin and risk of inflammatory bowel disease: a French nationwide study.","volume":"109","author":"Racine","year":"2014","unstructured":"20. Racine, A., Cuerq, A., Bijon, A., et al. Isotretinoin and risk of inflammatory bowel disease: a French nationwide study. (2014) Am J Gastroenterol 109(4): 563- 569.","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"issue":"12","key":"ref20","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/jamadermatol.2014.1540","article-title":"Isotretinoin exposure and risk of inflammatory bowel disease.","volume":"150","author":"Rashtak","year":"2014","unstructured":"21. Rashtak, S., Khaleghi, S., Pittelkow, M.R., et al. Isotretinoin exposure and risk of inflammatory bowel disease. (2014) JAMA Dermatol 150(12): 1322- 1326.","journal-title":"JAMA Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/2168-6068","issn-type":"print"},{"issue":"7","key":"ref21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1572-0241.2006.00632.x","article-title":"Possible association between isotretinoin and inflammatory bowel disease.","volume":"101","author":"Reddy","year":"2006","unstructured":"22. Reddy, D., Siegel, C.A., Sands, B.E., et al. Possible association between isotretinoin and inflammatory bowel disease. (2006) Am J Gastroenterol 101(7): 1569- 1573.","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"issue":"3","key":"ref22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jaad.2013.04.031","volume":"69","author":"Stobaugh","year":"2013","unstructured":"23. Stobaugh, D.J., Deepak, P., Ehrenpreis, E.D. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System. (2013) J Am AcadDermatol 69(3): 393- 398.","journal-title":"J Am Acad Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0190-9622","issn-type":"print"},{"issue":"5","key":"ref23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ajg.2011.28","article-title":"Isotretinoin use and the risk of inflammatory bowel disease.","volume":"106","author":"Thakrar","year":"2011","unstructured":"24. Thakrar, T.B., Robinson, N.J. Isotretinoin use and the risk of inflammatory bowel disease. (2011) Am J Gastroenterol 106(5): 1000- 1002.","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"}],"container-title":["Journal of Environment and Health Science"],"original-title":["English"],"link":[{"URL":"http:\/\/www.ommegaonline.org\/article-details\/Clarifying-the-Purported-Association-between-Isotretinoin-and-Inflammatory-Bowel-Disease\/85","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T16:36:09Z","timestamp":1691858169000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ommegaonline.org\/article-details\/Clarifying-the-Purported-Association-between-Isotretinoin-and-Inflammatory-Bowel-Disease\/85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,27]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.15436\/2378-6841.15.007","relation":{},"ISSN":["2378-6841"],"issn-type":[{"type":"electronic","value":"2378-6841"}],"subject":[],"published":{"date-parts":[[2015,3,27]]}}}